{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:27:46Z","timestamp":1787239666537,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,2,17]],"date-time":"2006-02-17T00:00:00Z","timestamp":1140134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ped Surgery Int"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s00383-006-1656-1","type":"journal-article","created":{"date-parts":[[2006,2,16]],"date-time":"2006-02-16T05:16:45Z","timestamp":1140067005000},"page":"562-564","source":"Crossref","is-referenced-by-count":12,"title":["Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis"],"prefix":"10.1007","volume":"22","author":[{"given":"Sendia","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Gura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Puder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,2,17]]},"reference":[{"key":"1656_CR1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00006454-198811000-00021","volume":"7","author":"Billstein","year":"1988","unstructured":"Billstein SA ,Sudol TE (1988) Ceftriaxone and biliary pseudolithiasis. Pediatr Infect Dis J 7:818\u2013820","journal-title":"Pediatr Infect Dis J"},{"key":"1656_CR2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF02012198","volume":"24","author":"C Blais","year":"1994","unstructured":"Blais C ,Duperval R (1994) Biliary pseudolithiasis in a child associated with 2\u00a0days of ceftriaxone therapy. Pediatr Radiol 24:218\u2013219","journal-title":"Pediatr Radiol"},{"key":"1656_CR3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1055\/s-2008-1072393","volume":"10","author":"JP Bonnet","year":"2000","unstructured":"Bonnet JP, Abid L, Dabhar A, Levy A, Soulier Y ,Blangy S (2000) Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children. Eur J Pediatr Surg 10:368\u2013371","journal-title":"Eur J Pediatr Surg"},{"key":"1656_CR4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1328-0867.2004.01884.x","volume":"46","author":"O Bor","year":"2004","unstructured":"Bor O, Dinleyici EC, Kebapci M ,Aydogdu SD (2004) Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study. Pediatr Int 46:322\u2013324","journal-title":"Pediatr Int"},{"key":"1656_CR5","first-page":"167","volume":"26","author":"JM Brogard","year":"1988","unstructured":"Brogard JM, Blickle JF, Jehl F, Arnaud JP, Paris-Bockel D ,Monteil H (1988) High biliary elimination of ceftriaxone in man. Int J Clin Pharmacol Ther Toxicol 26:167\u2013172","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"1656_CR6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00003495-199753030-00009","volume":"53","author":"RN Brogden","year":"1997","unstructured":"Brogden RN ,Spencer CM (1997) Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections. Drugs 53:483\u2013510","journal-title":"Drugs"},{"issue":"Suppl 1","key":"1656_CR7","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1007\/BF01644235","volume":"13","author":"JP Guggenbichler","year":"1985","unstructured":"Guggenbichler JP, Kofler J ,Allerberger F (1985) The influence of third-generation cephalosporins on the aerobic intestinal flora. Infection 13(Suppl 1):S137\u2013S139","journal-title":"Infection"},{"key":"1656_CR8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00871001","volume":"31","author":"W Hayton","year":"1986","unstructured":"Hayton W ,Stoeckel K (1986) Biliary excretion of ceftriaxone. Eur J Clin Pharmacol 31:123\u2013124","journal-title":"Eur J Clin Pharmacol"},{"key":"1656_CR9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1128\/AAC.34.6.1146","volume":"34","author":"KL Heim-Duthoy","year":"1990","unstructured":"Heim-Duthoy KL, Caperton EM, Pollock R, Matzke GR, Enthoven D ,Peterson PK (1990) Apparent biliary pseudolithiasis during ceftriaxone therapy. Antimicrob Agents Chemother 34:1146\u20131149","journal-title":"Antimicrob Agents Chemother"},{"key":"1656_CR10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s003300000647","volume":"11","author":"O Herek","year":"2001","unstructured":"Herek O, Pakdemirli E ,Kocer N (2001) Ceftriaxone-associated biliary pseudolithiasis in children. Eur Radiol 11:902","journal-title":"Eur Radiol"},{"key":"1656_CR11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00006454-198806000-00018","volume":"7","author":"RF Jacobs","year":"1988","unstructured":"Jacobs RF (1988) Ceftriaxone-associated cholecystitis. Pediatr Infect Dis J 7:434\u2013436","journal-title":"Pediatr Infect Dis J"},{"key":"1656_CR12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1440-1673.1998.tb00503.x","volume":"42","author":"DK Kearney","year":"1998","unstructured":"Kearney DK ,O\u2019Donnell D (1998) Iatrogenic gallstones: a ceftriaxone complication. Australas Radiol 42:236\u2013237","journal-title":"Australas Radiol"},{"key":"1656_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2214\/ajr.159.2.1632349","volume":"159","author":"WM Kirejczyk","year":"1992","unstructured":"Kirejczyk WM, Crowe HM, Mackay IM, Quintiliani R ,Cronin EB (1992) Disappearing \u201cgallstones\u201d: biliary pseudolithiasis complicating ceftriaxone therapy. AJR Am J Roentgenol 159:329\u2013330","journal-title":"AJR Am J Roentgenol"},{"key":"1656_CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1440-1754.2005.00613.x","volume":"41","author":"D Lemberg","year":"2005","unstructured":"Lemberg D, Day AS ,Wyeth B (2005) Biliary colic: Is it gallstones? J Paediatr Child Health 41:291\u2013293","journal-title":"J Paediatr Child Health"},{"key":"1656_CR15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-115-9-712","volume":"115","author":"AJ Lopez","year":"1991","unstructured":"Lopez AJ, O\u2019Keefe P, Morrissey M ,Pickleman J (1991) Ceftriaxone-induced cholelithiasis. Ann Intern Med 115:712\u2013714","journal-title":"Ann Intern Med"},{"key":"1656_CR16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00006454-199807000-00022","volume":"17","author":"MC Maranan","year":"1998","unstructured":"Maranan MC, Gerber SI ,Miller GG (1998) Gallstone pancreatitis caused by ceftriaxone. Pediatr Infect Dis J 17:662\u2013663","journal-title":"Pediatr Infect Dis J"},{"key":"1656_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00606428","volume":"22","author":"PJ McNamara","year":"1982","unstructured":"McNamara PJ, Stoeckel K ,Ziegler WH (1982) Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose. Eur J Clin Pharmacol 22:71\u201375","journal-title":"Eur J Clin Pharmacol"},{"key":"1656_CR18","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bmj.297.6652.858","volume":"297","author":"RH Meyboom","year":"1988","unstructured":"Meyboom RH, Kuiper H ,Jansen A (1988) Ceftriaxone and reversible cholelithiasis. Bmj 297:858","journal-title":"Bmj"},{"key":"1656_CR19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1097-0096(200005)28:4<166::AID-JCU2>3.0.CO;2-G","volume":"28","author":"A Palanduz","year":"2000","unstructured":"Palanduz A, Yalcin I, Tonguc E, Guler N, Ones U, Salman N, Somer A (2000) Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound 28:166\u2013168","journal-title":"J Clin Ultrasound"},{"key":"1656_CR20","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1651-2227.1999.tb01050.x","volume":"88","author":"F Papadopoulou","year":"1999","unstructured":"Papadopoulou F, Efremidis S, Karyda S, Badouraki M, Karatza E, Panteliadis C, Malaka K (1999) Incidence of ceftriaxone-associated gallbladder pseudolithiasis. Acta Paediatr 88:1352\u20131355","journal-title":"Acta Paediatr"},{"key":"1656_CR21","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/0016-5085(91)90667-A","volume":"100","author":"HZ Park","year":"1991","unstructured":"Park HZ, Lee SP ,Schy AL (1991) Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology 100:1665\u20131670","journal-title":"Gastroenterology"},{"key":"1656_CR22","first-page":"17","volume":"77","author":"IH Patel","year":"1984","unstructured":"Patel IH ,Kaplan SA (1984) Pharmacokinetic profile of ceftriaxone in man. Am J Med 77:17\u201325","journal-title":"Am J Med"},{"key":"1656_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(89)90228-6","volume":"2","author":"C Pigrau","year":"1989","unstructured":"Pigrau C, Pahissa A, Gropper S, Sureda D ,Martinez Vazquez JM (1989) Ceftriaxone-associated biliary pseudolithiasis in adults. Lancet 2:165","journal-title":"Lancet"},{"key":"1656_CR24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00247-003-0963-0","volume":"33","author":"JS Prince","year":"2003","unstructured":"Prince JS ,Senac MO Jr (2003) Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child. Pediatr Radiol 33:648\u2013651","journal-title":"Pediatr Radiol"},{"key":"1656_CR25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00003495-198427060-00001","volume":"27","author":"DM Richards","year":"1984","unstructured":"Richards DM, Heel RC, Brogden RN, Speight TM ,Avery GS (1984) Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 27:469\u2013527","journal-title":"Drugs"},{"key":"1656_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1542\/peds.98.1.133","volume":"98","author":"FM Robertson","year":"1996","unstructured":"Robertson FM, Crombleholme TM, Barlow SE, Verhave M ,Brown D (1996) Ceftriaxone choledocholithiasis. Pediatrics 98:133\u2013135","journal-title":"Pediatrics"},{"key":"1656_CR27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00006454-198611000-00026","volume":"5","author":"UB Schaad","year":"1986","unstructured":"Schaad UB, Tschappeler H ,Lentze MJ (1986) Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis 5:708\u2013710","journal-title":"Pediatr Infect Dis"},{"key":"1656_CR28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(88)90596-X","volume":"2","author":"UB Schaad","year":"1988","unstructured":"Schaad UB, Wedgwood-Krucko J ,Tschaeppeler H (1988) Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet 2:1411\u20131413","journal-title":"Lancet"},{"key":"1656_CR29","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/0016-5085(90)90486-K","volume":"99","author":"ML Shiffman","year":"1990","unstructured":"Shiffman ML, Keith FB ,Moore EW (1990) Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology 99:1772\u20131778","journal-title":"Gastroenterology"},{"key":"1656_CR30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/BF02074846","volume":"154","author":"A Stabile","year":"1995","unstructured":"Stabile A, Ferrara P, Marietti G ,Maresca G (1995) Ceftriaxone-associated gallbladder lithiasis in children. Eur J Pediatr 154:590","journal-title":"Eur J Pediatr"},{"key":"1656_CR31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0016-5085(90)91029-6","volume":"99","author":"Y Xia","year":"1990","unstructured":"Xia Y, Lambert KJ, Schteingart CD, Gu JJ ,Hofmann AF (1990) Concentrative biliary secretion of ceftriaxone. Inhibition of lipid secretion and precipitation of calcium ceftriaxone in bile. Gastroenterology 99:454\u2013465","journal-title":"Gastroenterology"},{"key":"1656_CR32","first-page":"1251","volume":"86","author":"J Zinberg","year":"1991","unstructured":"Zinberg J, Chernaik R, Coman E, Rosenblatt R ,Brandt LJ (1991) Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis. Am J Gastroenterol 86:1251\u20131254","journal-title":"Am J Gastroenterol"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-006-1656-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00383-006-1656-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-006-1656-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T10:14:24Z","timestamp":1683368064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00383-006-1656-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,17]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["1656"],"URL":"https:\/\/doi.org\/10.1007\/s00383-006-1656-1","relation":{},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"value":"0179-0358","type":"print"},{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,17]]}}}